Brainstorm Cell Therapeutics | BCLI - EPS Earnings Per Share

Stock Price
0.92
Daily Change
0.03 3.92%
Monthly
33.08%
Yearly
-33.94%
Q1 Forecast
0.82

Brainstorm Cell Therapeutics reported $-0.19 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.





Eps Change Date
Alterity Therapeutics Limited AUD 0 0 Dec/2023
Biogen USD 1.99 2.82 Dec/2025
Brainstorm Cell Therapeutics USD -0.19 0.15 Sep/2025
Cipla INR 15.2 1.52 Dec/2025
Clal Biotechnology ILS -0.04 0.1 Dec/2022
Compugen USD 0.59 0.67 Dec/2025
CSL USD 5.07 3 Dec/2025
Cytokinetics USD -1.5 1.05 Dec/2025
Gilead Sciences USD 1.86 0.61 Dec/2025
Grifols EUR 0.29 0.11 Mar/2026
Halozyme Therapeutics USD -0.24 1.96 Dec/2025
Mesoblast USD -0.03 0.01 Dec/2025